TB vaccines: Progress and problems

Trends in Immunology

Volumn 22, Issue 3, 2001, Pages 160-168

  Andersen, Peter ^a  

^a Statens Seruminstitut ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

85A ANTIGEN; 85B ANTIGEN; BCG VACCINE; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; DNA VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6 ANTIGEN; HEAT SHOCK PROTEIN 60; LIVE VACCINE; MICROSPHERE; MPT63 ANTIGEN; MPT64 ANTIGEN; MPT83 ANTIGEN; MTB41 ANTIGEN; PHOSPHORYL LIPID A; POLYLACTIDE; PSTS 1 ANTIGEN; PSTS 2 ANTIGEN; PSTS 3 ANTIGEN; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; BACTERIAL GENE; BCG VACCINATION; CELL INTERACTION; CELLULAR IMMUNITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; HUMAN; LUNG TUBERCULOSIS; NONHUMAN; PROBLEM SOLVING; REVIEW; T LYMPHOCYTE; TREATMENT FAILURE;

ANIMALS; ANTIGENS, BACTERIAL; BCG VACCINE; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, CELLULAR; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 0034913656     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(01)01865-8     Document Type: Review

References (77)

1. Is the development of a new tuberculosis vaccine possible?
2. The BCG story: Lessons from the past and implications for the future
3. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
4. Comparative genomics of BCG vaccines by whole-genome DNA microarray
5. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays
6. Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens
7. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice
8. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis
9. The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG
10. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis
11. Immunity to mycobacteria with emphasis on tuberculosis: Implications for rational design of an effective tuberculosis vaccine
12. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guérin
13. Interferon-gamma receptor deficiency in an infant with fatal Bacille Calmette-Guérin infection
14. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients
15. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection
16. Adjuvant modulation of immune responses to tuberculosis subunit vaccines
17. Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection
18. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis
19. Granulysin: A lethal weapon of cytolytic T cells
20. Increase in gamma interferon-secreting CD8(+), as well as CD4(+), T cells in lungs following aerosol infection with Mycobacterium tuberculosis
21. Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice
22. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection
23. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis
24. Immune response to Mycobacterium bovis bacille Calmette-Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: Contribution of CD4 and CD8 T cells to acquired resistance
25. + T cells mediate adoptive immunity to aerosol infection of Mycobacterium bovis bacillus Calmette-Guérin
26. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells
27. Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2
28. The CD-1 restricted T-cell response to mycobacteria
29. Vaccines against intracellular infections requiring cellular immunity
30. Does the efficacy of BCG decline with time since vaccination?
31. Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection
32. + T cell memory, CD45R subsets and the persistence of antigen - A unifying concept
33. CD4(+) T-cell subsets that mediate immunological memory to Mycobacterium tuberculosis infection in mice
34. Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: Towards functional genomics of microbial pathogens
35. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family
36. Stationary phase-associated protein expression in Mycobacterium tuberculosis: Function of the mycobacterial alpha-crystallin homolog
37. Protection against mycoplasma infection using expression-library immunization
38. From genomics to vaccines: Malaria as a model system
39. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis
40. Human T-cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis
41. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen
42. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment
43. Vaccination against tuberculosis by DNA injection
44. Therapy of tuberculosis in mice by DNA vaccination
45. Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode
46. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine
47. In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis
48. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis
49. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice
50. Has BCG attenuated to impotence?
51. Recombinant bacillus Calmette-Guérin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model
52. Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes
53. Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines
54. The 19-kD antigen and protective immunity in a murine model of tuberculosis
55. Lack of protection in mice and necrotizing bronchointerstitial pneumonia with bronchiolitis in guinea pigs immunized with vaccines directed against the hsp60 molecule of Mycobacterium tuberculosis
56. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins
57. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis
58. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis
59. Intranasal vaccination of mice against infection with Mycobacterium tuberculosis
60. ESAT-6 subunit vaccination against Mycobacterium tuberculosis
61. Protective efficacy of mycobacterial 71 kDa cell wall associated protein using poly (DL-lactide-co-glycolide) microparticles as carrier vehicles
62. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis
63. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
64. + T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection
65. The immunogenicity of single and combination DNA vaccines against tuberculosis
66. Mycobacterium tuberculosis-secreted protein antigens: Immunogenicity in baboons
67. + T lymphocytes specific for Mycobacterium tuberculosis
68. Specific immune-based diagnosis of tuberculosis
69. In vitro measurement of protective mycobacterial immunity: Antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guérin
70. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis
71. DNA vaccination against tuberculosis: Expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity
72. Protection against Mycobacterium avium by DNA vaccines expressing mycobacterial antigens as fusion proteins with green fluorescent protein
73. Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors
74. T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection
75. Characterization of the memory/activated T cells that mediate the long-lived host response against tuberculosis after bacillus Calmette-Guérin or DNA vaccination